Â¥
9.10
Jan 3
New Key Statistics Module, Z-Score and F-Score
SZSE:002728 Key Ratios
Market Cap ¥ M | 4,648.18 |
Enterprise Value ¥ M | 4,529.95 |
P/E(ttm) | 63.64 |
PE Ratio without NRI | 54.82 |
Forward PE Ratio | 13.27 |
Price/Book | 2.67 |
Price/Sales | 6.21 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 3.01 |
Revenue (TTM) ¥ M | 777.00 |
EPS (TTM) ¥ | 0.14 |
Beneish M-Score | -1.9 |
10-y EBITDA Growth Rate % | 9.60 |
5-y EBITDA Growth Rate % | 2.80 |
y-y EBITDA Growth Rate % | -75.60 |
EV-to-EBIT | 55.36 |
EV-to-EBITDA | 55.36 |
PEG | 19.58 |
Shares Outstanding M | 510.79 |
Net Margin (%) | 9.09 |
Operating Margin % | 10.95 |
Pre-tax Margin (%) | 9.71 |
Quick Ratio | 1.06 |
Current Ratio | 1.46 |
ROA % (ttm) | 2.87 |
ROE % (ttm) | 3.80 |
ROIC % (ttm) | 4.17 |
Dividend Yield % | 5.69 |
Altman Z-Score | 4.49 |
SZSE:002728 Number of Guru Trades
SZSE:002728 Volume of Guru Trades
Gurus Latest Trades with SZSE:002728
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002728 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Teyi Pharmaceutical Group Co Ltd Insider Transactions
No Available Data